Prospective Study for Symptomatic Relief of ET With Cala Therapy

NACompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Essential Tremor
Interventions
DEVICE

Cala TWO

Wrist-worn stimulator which applies a tremor-customized stimulation pattern to an individual's nerves

Trial Locations (32)

10003

Mount Sinai & Beth Isreal, New York

10017

Parkinson's Disease and Movement Disorders Center of Long Island, Long Island City

19104

University Of Pennsylvania Medicine, Philadelphia

19144

Jefferson University, Philadelphia

20007

Medstar Gerogetown Health Institute, Georgetown

20774

Kaiser Mid-Atlantic Group, Largo

27157

Wake Forest, Raleigh

27710

Duke University, Durham

30912

Augusta University, Augusta

33486

Parkinson's Center, Boca Raton

33612

USF, Tampa

44195

Cleveland Clinic, Cleveland

45255

River Hills Neuroscience, Cincinnati

48322

Henry Ford Health System, West Bloomfield

55902

Mayo Clinic, Rochester

60612

Rush University Medical Center, Chicago

66160

Kansas University Medical Center, Kansas City

75390

University of Texas Southwestern, Dallas

77030

Houston Methodist, Houston

78628

Texas Movement Disorder Specialist, Georgetown

78681

Central Texas Neurology Consultants, Round Rock

80113

Rocky Mountain Movement Disorders Center, Denver

85013

Barrow Neurological Institute (Dignity Health), Phoenix

90033

USC, Los Angeles

90404

Pacific Neuroscience Institute, Santa Monica

94040

Parkinson's Institute and Clinical Center, Mountain View

94143

University of California San Francisco, San Francisco

95405

Advanced Neurology Specialists, Great Falls

98004

Swedish, Bellevue

98034

EvergreenHealth Medical Center, Kirkland

06053

Hospital for Special Care, New Britain

02215

Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cala Health, Inc.

INDUSTRY